$12.93
-1.07-7.64%
마지막 업데이트: Oct 16, 4:00 PM
$12.93
-1.07-7.64%
Benzinga
Benzinga
Benzinga
토요일, 10월 17
Benzinga
© 2026 Benzinga | All Rights Reserved
Cullinan Therapeutics (CGEM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.82 | $-0.84 | $-0.82 | $-0.92 |
| Actual | $-0.81 | $-0.75 | $-0.77 | $-0.77 |
| Surprise | +1.22% | +10.7% | +6.10% | +16.3% |
| Revenue | ||||
| Estimate | $7.0M | $3.5M | $9.9M | — |
| Actual | $0 | $0 | — | — |
| Surprise | -100.0% | -100.0% | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.83 | $-0.70 | $-0.41 | $-0.71 |
| Revenue | ||||
| Consensus | $402000 | $16.2M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.81 | $-0.82 | 1.22 % |
| Q1 | May 7, 2026 | $-0.75 | $-0.84 | 10.7 % |
| Q4 | Mar 10, 2026 | $-0.77 | $-0.82 | 6.10 % |
| Q3 | Nov 6, 2025 | $-0.77 | $-0.92 | 16.3 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $6.96M | -100.0 % |
| Q1 | May 7, 2026 | $0 | $3.47M | -100.0 % |
| Q4 | Mar 10, 2026 | $0 | $9.94M | -100.0 % |